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Immunolabeling for adenosine A1 receptors (A1Rs) is high in hippocampal area CA2 in
adult rats, and the potentiating effects of caffeine or other A1R-selective antagonists
on synaptic responses are particularly robust at Schaffer collateral synapses in CA2.
Interestingly, the pronounced staining for A1Rs in CA2 is not apparent until rats are
4 weeks old, suggesting that developmental changes other than receptor distribution
underlie the sensitivity of CA2 synapses to A1R antagonists in young animals. To evaluate
the role of A1R-mediated postsynaptic signals at these synapses, we tested whether
A1R agonists regulate synaptic transmission at Schaffer collateral inputs to CA2 and
CA1. We found that the selective A1R agonist CCPA caused a lasting depression of
synaptic responses in both CA2 and CA1 neurons in slices obtained from juvenile
rats (P14), but that the effect was observed only in CA2 in slices prepared from
adult animals (∼P70). Interestingly, blocking phosphodiesterase activity with rolipram
inhibited the CCPA-induced depression in CA1, but not in CA2, indicative of robust
phosphodiesterase activity in CA1 neurons. Likewise, synaptic responses in CA2 and
CA1 differed in their sensitivity to the adenylyl cyclase activator, forskolin, in that it
increased synaptic transmission in CA2, but had little effect in CA1. These findings
suggest that the A1R-mediated synaptic depression tracks the postnatal development
of immunolabeling for A1Rs and that the enhanced sensitivity to antagonists in CA2 at
young ages is likely due to robust adenylyl cyclase activity and weak phosphodiesterase
activity rather than to enrichment of A1Rs.
Keywords: adenosine, phosphodiesterase, adenylyl cyclase, synapse, long-term depression (LTD), hippocampus
Abbreviations: Adenosine, 9-β-D-ribofuranosyl-9H-purin-6-amine; AP5, 2-amino-5-phosphonovaleric acid; CCPA, 2-
chloro-N-cyclopentyladenosine; Forskolin, [3R-(3α,4aβ,5β,6β,6aα,10α,10aβ,10bα)]-5-(Acetyloxy)-3-ethenyldodecahydro-6,
10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one; Fostriecin, (6R)-5,6-dihydro-6-[(1E,3R,4R,6R,
7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-2H-pyran-2-one; KT5720, (9R,10S,
12S)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9, 12-epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]
benzodiazocine-10-carboxylic acid; PKI, Protein Kinase A inhibitor fragment (6–22) amide Thr-Tyr-Ala-Asp-Phe-Ile-
Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2; Rolipram, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one;
SB203580, 4-[5-(4-fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1H-imidazol-4-yl]pyridine.
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INTRODUCTION
Caffeine acts as a stimulant when consumed by humans, and in
some individuals, it may trigger or even exacerbate symptoms
of anxiety or psychosis (Lucas et al., 1990; Broderick and
Benjamin, 2004). Although the precise cellular mechanisms
underlying both the beneficial and detrimental effects of caffeine
on cognition remain largely unknown, studies in rodents
provide powerful insight into caffeine’s mode of action. Strong
evidence links adenosine receptors and in particular the A1
receptor (A1R) subtype, as major targets of caffeine (Nehlig
et al., 1992; Jacobson et al., 1996). Interestingly, mice lacking
A1Rs show increased aggression and anxiety-like behaviors
(Giménez-Llort et al., 2002). Indeed, one brain area that has
been associated with social aggression and social recognition
memory in hippocampal area CA2 (Hitti and Siegelbaum,
2014; Stevenson and Caldwell, 2014; Pagani et al., 2014).
This is notable because pyramidal neurons in CA2 show the
highest labeling for A1Rs in the entire hippocampus (Ochiishi
et al., 1999). Consistent with the high expression of A1Rs in
CA2 is the observation that caffeine and other A1R antagonists
preferentially enhance excitatory synaptic transmission in area
CA2 at concentrations that have little effect on responses in
CA1 and CA3 (Simons et al., 2012). This potentiation differs
from typical activity-dependent forms of long-term potentiation
(LTP) in that it does not require activation of N-methyl-D-
aspartate (NMDA) receptors, a rise in postsynaptic calcium,
or activity of Ca2+/calmodulin-dependent protein kinase II.
It is however, blocked by inhibitors of adenylyl cyclase and
postsynaptic protein kinase A (PKA; Simons et al., 2012).
Although presynaptic A1Rs are known to regulate glutamate
exocytosis (Dunwiddie and Hoffer, 1980; Prince and Stevens,
1992; Dunwiddie and Masino, 2001), the effects of caffeine
on the release probability of neurotransmitter did not differ
between areas CA2 and CA1, suggesting that the CA2-specific
potentiating effects of A1R antagonists are due to actions
mediated mainly by postsynaptic A1Rs in CA2 pyramidal
neurons (Ochiishi et al., 1999; Simons et al., 2012; but see Muñoz
and Solís, 2019).
A difficult finding to reconcile is the observation by Ochiishi
et al. (1999) that immunolabeling for the A1R is uniform
in the pyramidal cell layer across the CA fields in young
rats, with virtually no difference in labeling between areas
CA2 and CA1 at postnatal day 14, the approximate age
of animals used previously by Simons et al. (2012). It is
only at older ages—P28 and above—that staining for the
A1R is most pronounced in CA2 neurons. Curiously, the
robust differences between CA2 and CA1 in their ability to
support A1R-mediated synaptic potentiation do not mirror
the developmental expression pattern of the A1R observed in
young rats. Possible explanations to account for this discrepancy
may involve key downstream signaling molecules that regulate
either the production (via adenylyl cyclases) or degradation
(via phosphodiesterases) of cyclic adenosine monophosphate
(cAMP). Because A1Rs couple to Gi/o type G proteins to
decrease the activity of adenylyl cyclase and constrain the
production of cAMP (Fredholm et al., 2011), we assessed
whether activation of A1Rs would induce synaptic depression
in Schaffer collateral inputs to CA2 and CA1. Importantly,
we tested whether transmission at these synapses differed in
their responses to A1R agonists in an age-dependent manner.
Finally, we tested whether pharmacological manipulation of
the postsynaptic signals recruited by activation of A1Rs would
unmask differences in synaptic responses evoked in areas
CA1 and CA2 in brain slices prepared from juvenile rats,
possibly explaining the differences observed between the two
subfields in response to an array of A1R-selective antagonists,
including caffeine.
MATERIALS AND METHODS
Tissue Slices
Methods for obtaining whole-cell voltage-clamp and current-
clamp recordings were similar to those described previously
(Caruana et al., 2011; Simons et al., 2012; Pagani et al., 2014).
Briefly, brain slices were prepared from juvenile (P14–18) male
or female Sprague–Dawley rats, as well as from adult males
(P60–70; Charles River Laboratories). Animals were anesthetized
with sodium pentobarbital (65 mg/kg, i.p.), decapitated and
the brains were rapidly removed and transferred into the
ice-cold sucrose-substituted artificial cerebrospinal fluid (ACSF)
containing (in mM): 240 sucrose, 2.0 KCl, 1 MgCl2, 2 MgSO4,
1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 D-glucose, and
saturated with 95% O2 and 5% CO2. Coronal brain slices
(340 µm thick) containing the dorsal hippocampus were taken
from sections located within −2.30 and −4.30 mm posterior
to Bregma (Paxinos and Watson, 1998). Slices were cut using
a vibratome (VT1200S, Leica Biosystems) and then placed
in a holding chamber containing normal ACSF (warmed to
32◦C), and slices recovered for at least 1 h before experimental
recordings. Standard ACSF consisted of the following (in
mM): 124 NaCl, 2.5 KCl, 2 MgCl2, 2 CaCl2, 1.25 NaH2PO4,
26 NaHCO3 and 17 D-glucose. After the recovery period,
slices were transferred individually to a recording chamber and
visualized using an upright microscope (BX51WI, Olympus
Corp.) equipped with differential interference contrast optics,
a 40× water-immersion objective and a near-infrared camera
(RC300, Dage-MTI). Submerged slices were superfused with
oxygenated ACSF at a rate of 2.0 ml/min at room temperature
(∼25◦C).
Stimulation and Recording
The whole-cell voltage or current-clamp recordings from
hippocampal pyramidal neurons were made using patch pipettes
filled with a solution containing the following (in mM):
120 K-gluconate, 10 KCl, 3 MgCl2, 0.5 EGTA, 40 HEPES,
2 Na2-ATP and 0.3 Na-GTP, with pH adjusted to 7.2 by KOH.
Electrodes were prepared from borosilicate glass (filamented,
1.5 mm OD; 2.5–3.5 M; King Precision Glass) using a
horizontal puller (P-97, Sutter Instrument Co.), and experiments
on CA2 neurons were performed only when area CA2 could
be distinguished visually from area CA1. Pipettes were placed
in contact with somata of visually-identified pyramidal neurons
in CA2 and CA1 and gentle suction was applied under voltage
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clamp to form a tight seal (1–3 G). Whole-cell configuration
was achieved by increased suction, and experiments began after
cells stabilized (typically within 10–15 min following break-
in). Electrophysiological properties of CA2 neurons such as the
amplitude of the sag in response to hyperpolarizing currents,
capacitance, or resting membrane potentials, while significantly
different from neurons in CA1 or CA3 as a group (Zhao et al.,
2007 for the rat; San Antonio et al., 2013; Sun et al., 2017 for
mice), were varied enough to make them unreliable indicators
of CA2 neuron identity due to the large overlap in values.
Therefore, the approximate position of CA2 was estimated
based on the appearance of the cells (vs. generally unhealthy-
appearing CA3 neurons) and position relative to the upper
blade of the dentate gyrus. Differences in pharmacology between
presumed CA2 neurons and CA1 neurons provided further
evidence that we were recording from different populations
of neurons.
Voltage clamp recordings (Vh = −70 mV) were obtained
using an Axopatch 200B amplifier (Molecular Devices Inc., San
Jose, CA, USA) and displayed on a computer monitor using
the software package WinLTP (WinLTP Limited). Recordings
were filtered at 5 kHz and digitized at 20 kHz (Digidata 1322A,
Molecular Devices Inc., San Jose, CA, USA). No correction was
applied to compensate for liquid junction potentials. Only cells
with a series resistance (Rs) < 25 M and a <20% change
in Rs from baseline during an experiment were included for
analysis. Synaptic responses in CA2 and CA1 pyramidal neurons
were evoked using cluster-style electrodes (CE2C75, FHC Inc.)
placed∼150µm from recorded neurons in the stratum radiatum
at a location intended to stimulate the Schaffer collaterals (see
Figures 1A1,B1). Synaptic responses were evoked with 0.1 ms
constant current pulses delivered using a stimulus isolation
unit (BSI-2A, BAK Electronics) and stimulation intensity was
adjusted to evoke synaptic currents approximately 75% of
maximal amplitude (range; 75–200 µA). Single test pulses or
pairs of stimulation pulses (with a 50 ms interpulse interval) were
delivered to the Schaffer collaterals every 20 s to evoke excitatory
postsynaptic currents (EPSCs). In some experiments, EPSCs
were evoked by stimulation intensities ranging from 10 to 200µA
delivered in ascending steps (input-output tests). Protocols for all
synaptic recording experiments were configured and controlled
using WinLTP. The intrinsic excitability of pyramidal neurons
in CA2 and CA1 was determined by measuring changes in
membrane potential following the injection of hyperpolarizing
and depolarizing current steps in current-clamp mode using
the software package pClamp (Molecular Devices Inc., San Jose,
CA, USA).
Data Analysis
Evoked synaptic currents were analyzed using the software
applications WinLTP and AxoGraph X (AxoGraph Scientific).
Peak amplitudes of EPSCs were measured relative to the
prestimulus baseline (8–2 ms period before stimulation pulse),
and paired-pulse facilitation (PPF) was determined by expressing
the amplitude of the second response as a proportion of the
amplitude of the first response. During synaptic recordings,
input resistance (Rin) was calculated by measuring the amplitude
of the steady-state current evoked during a −5 mV voltage
step (50 ms duration) delivered 100 ms before test stimulation,
and Rs was calculated by measuring the peak amplitude of the
fast capacitive transient observed at the onset of the voltage
step. The coefficient of variation (1/CV2; where C = mean
and V = standard deviation) was calculated on the mean
amplitude of responses obtained during 10 min epochs of stable
recordings of EPSCs using Excel (Microsoft Corporation). The
stability of responses was first confirmed by testing the slope
of a regression line fit through data points included for 1/CV2
analyses, and results for 1/CV2 analyses were normalized to
the baseline for plotting. The effects of bath- or intracellularly-
applied drugs during pharmacological experiments were assessed
on the amplitude of averaged EPSCs obtained during 5-min-
long epochs recorded at different times during an experiment
(latencies specified below). Also, experiments were interleaved
so that no single experiment was performed twice in slices
prepared from the same animal. All data were expressed as
the mean ± SEM and were normalized to baseline recordings
for plotting. Changes in response properties were assessed
with Prism (GraphPad Software Inc.) using (where appropriate)
paired or unpaired samples t-tests, one-way ANOVAs, or
repeated-measures ANOVAs. Post hoc comparisons were made
using the Bonferroni or Tukey methods with the alpha level set
to P < 0.05.
The intrinsic excitability of pyramidal neurons was assessed
by counting the number of spikes evoked in response to
500 ms-duration suprathreshold depolarizing current steps
(0–100 pA in ascending 20 pA increments) from a constant
holding potential (typically rest). Input resistance was calculated
by measuring both the peak and the steady-state voltage
responses to −100 pA current steps (500 ms in duration),
and inward rectification was quantified by expressing the peak
input resistance as a proportion of the steady-state resistance
(rectification ratio). All data were expressed as the mean ± SEM
for plotting, and changes in response properties were assessed
using paired samples t-tests.
Pharmacology
Unless stated, all compounds used for pharmacological
experiments were obtained from Sigma and prepared as
concentrated stock solutions (typically 10–50 mM) by dilution
in (where appropriate) either distilled water or dimethyl
sulfoxide and stored at −20◦C until required. Compounds
were either bath-applied or loaded intracellularly via the patch
recording pipette.
RESULTS
Effects of Adenosine and an A1R Agonist
on Synaptic Transmission in CA2 and CA1
EPSCs were evoked in CA2 or CA1 by stimulating the Schaffer
collaterals. The schematic diagrams are shown in Figure 1
highlight the placement of stimulating and recording electrodes
in coronal slices of the dorsal hippocampus for experiments
assessing evoked synaptic responses in area CA2 (Figure 1A1)
or in area CA1 (Figure 1B1). Synaptic responses were stable for
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FIGURE 1 | Adenosine has transient suppressive effects on synaptic transmission in hippocampal areas CA2 and CA1. Illustrated are the approximate locations of
stimulating electrodes relative to recording electrodes in slices of the dorsal hippocampus (A1, CA2, in red; B1, CA1, in black; colors are consistent for each figure).
Stimulating electrodes were positioned in the stratum radiatum to activate Shaffer Collateral axons. (A2,B2) Mean (±SEM) excitatory postsynaptic current (EPSC)
amplitudes recorded from CA2 and CA1, respectively, for 60 min without treatment. Data from these graphs are plotted in subsequent figures for statistical
comparison. The amplitude of EPSCs has been normalized to the pre-treatment baseline for plotting in this and subsequent figures. Inset traces in (A2–4,B2–4) are
averaged EPSCs (average of three consecutive sweeps over a 1-min period in this and subsequent figures) from representative experiments at the times indicated by
the numbers. (A3,4,B3,4) Bath-application of adenosine (ADO; obtained from Sigma) for 5 min, indicated by the shaded region, induces only a transient suppression
of EPSCs in the hippocampus and only at a concentration of 10 µM (A4,B4). This effect was highly variable and depended on the commercial source of the
adenosine (data not shown). Note: recordings were made from slices prepared from juvenile rats (P14 to P18) in this and subsequent figures unless
specified otherwise.
60 min (CA2, Figure 1A2; CA1, Figure 1B2), and the amplitude
of EPSCs did not change significantly during the course of
interleaved, age-matched and untreated control experiments
(CA2, baseline vs. last 5-min, t(5) = 0.11, P = 0.92, n = 6;
CA1, baseline vs. last 5-min, t(6) = 0.37, P = 0.72, n = 7). To
determine whether activation of adenosine receptors induces
a lasting depression of synaptic responses in CA2 neurons,
EPSCs were monitored before, during, and after a brief 5-min-
long bath-application of adenosine. We found that although
10 µM adenosine significantly suppressed synaptic transmission
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during the first 10 min following the onset of drug application
(to 51.8 ± 4.8% of baseline, F(1,9) = 10.62, P < 0.01,
Bonferroni P < 0.001, n = 5; Figure 1A4), responses returned
to baseline levels quickly during washout and remained stable
for the remainder of the experiment (at 110.21 ± 15.31% of
baseline during the last 5-min, Bonferroni P = 0.88). Unlike
the potentiating effects of A1R antagonists, which were more
pronounced in CA2 (Simons et al., 2012), the effects of
adenosine in CA2 did not differ significantly from those in CA1
(compare data shown in Figures 1A3,4,B3,4). Synaptic responses
in Schaffer collateral inputs to CA1 were depressed significantly
to 43.19 ± 4.71% of baseline (F(1,9) = 89.33, P < 0.0001,
Bonferroni P < 0.0001, n = 4, Figure 1B4) by 10 µM adenosine
and returned quickly to baseline levels during washout (to
102.96 ± 3.01% of baseline, Bonferroni P > 0.999). We note,
however, that the adenosine-mediated suppression of EPSCs in
both CA2 and CA1 was highly variable and depended on the
commercial source of the adenosine, with effects ranging from
no suppression of EPSCs (using adenosine obtained from Tocris
Bioscience; similar to the non-significant results observed using
1 µM adenosine shown for CA2 in Figure 1A3, n = 4; and for
CA1 in Figure 1B3, n = 4) to brief potentiation (Garaschuk et al.,
1992; adenosine from Ascent Scientific; data not shown).
Given the variability of the adenosine-mediated effects
described above, we reasoned that the stability of adenosine may
be problematic and that use of an A1R agonist may produce
more stable and consistent results. Additionally, an agonist
would have the advantage of selectivity for the A1R over other
adenosine receptor subtypes that are known to be expressed
in the hippocampus and would not be subject to degradation
by endogenous enzymes. Indeed, a 5-min application of the
selective A1R agonist 2-chloro-N6-cyclopentyladenosine (CCPA;
Lohse et al., 1988; 100 nM; Figure 2A1) induced a robust
decrease in the amplitude of synaptic responses recorded in
CA2 pyramidal neurons, lasting for at least 50 min. EPSCs were
depressed significantly to 32.44 ± 4.27% of baseline within the
first 15-min of washout relative to age-matched and untreated
control responses (F(1,11) = 7.84, P< 0.05, Bonferroni P< 0.0001,
n = 7, Figure 2B1), and EPSCs remained significantly depressed
at 61.81 ± 9.38% of baseline by the end of the experiment
(Bonferroni P < 0.001). The suppression of synaptic responses
in CA2 was apparent across a range of stimulation intensities and
concentrations of CCPA. The amplitude of synaptic responses in
area CA2 increased in proportion to the intensity of electrical
stimulation delivered to the Schaffer collaterals, and this was
significantly reduced by CCPA when assessed 15 min into the
washout period for all but the lowest stimulation intensity tested
(F(6,54) = 27.72, P < 0.001, Bonferroni P < 0.001 for 25–200 µA,
n = 10, Figure 2A2). The effect of CCPA on synaptic responses in
CA2 was also tested following bath-application of three different
concentrations of CCPA (10 nM, n = 5; 100 nM, n = 7; and
1 µM, n = 1), but a depression of EPSCs lasting longer than
15 min was observed only with the two highest concentrations
(see Figure 2A3).
Similar to the short-lasting effects of adenosine shown in
Figure 1, the CCPA-mediated depression of EPSCs observed
in CA2 did not differ significantly from the depression
induced in area CA1 following the same experimental protocols.
Bath-application of 100 nM CCPA significantly depressed the
amplitude of EPSCs in CA1 to 24.82 ± 3.12% of baseline
within the first 15-min of washout relative to age-matched
and untreated control responses (F(1,10) = 22.32, P < 0.001,
Bonferroni P < 0.0001, n = 5, Figure 2B4), and EPSCs remained
significantly depressed at 52.55± 8.59% of baseline by the end of
the experiment (Bonferroni P < 0.001). And as noted above, the
magnitude of the suppression of synaptic responses induced by
100 nM CCPA did not differ between area CA2 and CA1 at the
time points assessed (F(1,10) = 0.02, P = 0.893; peak, Bonferroni
P = 0.939; last 5-min, Bonferroni P = 0.762; data not shown;
see also Figures 3A2,3). Bath-application of 100 nM CCPA also
induced a significant suppression of synaptic responses across
a range of stimulation intensities in area CA1 (F(6,48) = 5.26,
P < 0.001, Bonferroni P < 0.01 for 25 µA and P < 0.0001 for
50–200 µA, n = 9, Figure 2B2), but interestingly, the magnitude
of the suppression was greater in area CA2 than in CA1 at
the two highest stimulation intensities tested (F(6,102) = 2.51,
P < 0.05, Bonferroni P < 0.05 at 150 and 200 µA, respectively;
compare Figures 2A2,B2). The effect of A1R activation on EPSCs
in CA1 was also tested following bath-application of multiple
concentrations of CCPA (10 nM, n = 5; 100 nM, n = 5; and 1
µM, n = 1), but similar to area CA2, a depression of synaptic
responses lasting longer than 15 min was observed only with the
two highest concentrations of CCPA (see Figure 2B3). Note that
we cannot distinguish between the long-lasting biological effects
of A1R activation and incomplete wash-out of the drug with
continuing activation of the receptors. These findings suggest
that the effects of selective A1R activation, unlike A1R blockade
(Simons et al., 2012), are similar in CA1 and CA2 neurons at
young postnatal ages (P14 to P18; see Figures 3A2,3) and closely
reflect the developmental expression pattern of A1Rs in the
hippocampus (see schematic summary in Figure 3A1; Ochiishi
et al., 1999).
Developmental Differences in
A1R-Mediated Synaptic Depression in the
Hippocampus
To determine whether the A1R-mediated depression of EPSCs
differs in CA2 and CA1 at an age when A1R expression is known
to be highest in area CA2 (Ochiishi et al., 1999; Figure 3B1),
we tested the effects of 100 nM CCPA on evoked synaptic
responses in CA2 and CA1 neurons in slices prepared from adult
rats. We found that in slices from adult animals (∼P70), CCPA
induced a significantly greater depression of synaptic responses
in CA2 than in CA1 (F(1,20) = 6.37, P < 0.05, Figures 3B2,3).
EPSCs were depressed to 53.57± 6.66% of baseline levels in area
CA2 (n = 6) when assessed at the end of the experiment, whilst
responses in CA1 returned to baseline levels (to 83.94 ± 5.12%,
n = 6; Bonferroni P < 0.05, Figures 3B2,3). These data suggest
that the A1R-mediated suppression of EPSCs induced by CCPA
closely follows the pattern of immunolabeling for A1Rs at both
early and late postnatal ages in rats.
Adenosine, acting on A1Rs, has been shown previously
to reduce glutamate release (Dunwiddie and Hoffer, 1980;
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FIGURE 2 | Selective activation of A1 receptors (A1Rs) with CCPA induces synaptic depression in both CA2 and CA1. Bath application of the A1R-selective agonist
CCPA (100 nM; gray bar) induced a significant depression in the amplitude of EPSCs in both CA2 (A1) and CA1 (B1). Inset and averaged traces are from a
representative experiment at times indicated by the numbers. Recordings from age-matched and untreated control slices are shown in gray for comparison. (A2,B2)
The depression of EPSCs induced by 100 nM CCPA is evident across a wide range of stimulation intensities when assessed 15-min into the washout period for area
CA2 and CA1, respectively. Inset and colored traces (above) are from representative experiments at the stimulation intensities indicated by the corresponding colored
bars (below). (A3,B3) Effects of three doses of CCPA (10 nM, 100 nM, and 1 µM; gray bar) on EPSC amplitudes recorded in CA2 and CA1, respectively. Overall, the
effects of CCPA on synaptic function did not differ significantly between areas CA2 and CA1.
Prince and Stevens, 1992). As such, we assessed whether CCPA
was acting presynaptically to induce the depression of excitatory
synaptic responses observed in both CA2 and CA1 in slices
obtained from young animals. One assessment of presynaptic
function that is useful in determining whether changes in
synaptic transmission can be attributed to changes in the release
probability of glutamate is the test of (PPF; Creager et al., 1980;
Zucker, 1989; Zucker and Regehr, 2002). Adenosine has been
reported to increase PPF, reflecting a decrease in glutamate
release from presynaptic terminals (Harris and Cotman, 1985;
Dumas and Foster, 1998; Manita et al., 2007). We found that
concurrent with the depression in synaptic responses induced
by 100 nM CCPA, PPF (using a 50 ms interpulse interval)
increased in some cases. The effect was inconsistent across
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FIGURE 3 | The A1R-mediated depression of EPSPs closely mirrors the developmental expression pattern of A1Rs in CA2 and CA1. Immunolabeling for A1Rs, as
reported by Ochiishi et al. (1999), is homogeneous across Ammon’s horn in early postnatal development (depicted in A1), and A1R expression becomes markedly
more pronounced in CA2 and weaker in CA1 during adulthood (depicted in B1). Mirroring this is the observation that the CCPA-mediated depression of EPSCs
(100 nM) is similar in both CA1 and CA2 in slices obtained from P14 rats (A2,3). Further, the A1R-mediated depression induced by CCPA increases with age in CA2,
yet decreases with age in CA1 (∼P70; B2,3). *p < 0.05, ns, not significant.
slices and did not reach statistical significance in either CA2
(increase to 117.0 ± 8.01% of baseline, t(4) = 2.14, P = 0.099,
n = 5, Figures 4A1,2) or CA1 (increase to 130.1 ± 14.6% of
baseline, t(3) = 2.13, P = 0.122, n = 4, Figures 4B1,2). An
additional measure of presynaptic function that may reflect
changes induced by the application of CCPA is the coefficient
of variation (1/CV2; Caruana et al., 2011; Pagani et al., 2014).
Here, 1/CV2 was computed for 10-min epochs of stable EPSCs
recorded during the baseline period and at the very end of
the experiment. Response-to-response variability was increased
by CCPA as indicated by a reduction in 1/CV2 in both CA2
(to 59.17 ± 6.14% of baseline, n = 7, Figure 4A3) and CA1
(to 40.48 ± 8.65% of baseline, n = 5, Figure 4B3), and this
suggests that CCPA may have been acting on presynaptic A1Rs
to suppress glutamate release and regulate synaptic function.
However, the reduction in 1/CV2 observed at the end of
the experiment did not differ significantly from baseline in
either CA2 (t(6) = 2.23, P = 0.066) or CA1 (t(4) = 1.95,
P = 0.123). Data for 1/CV2 analyses obtained during the last
10-min of the experiment were also expressed as a ratio of
the baseline and plotted against the CCPA-mediated change
in the amplitude of EPSCs for each individual experiment
(CA2, Figure 4A4, all cells; CA1, Figure 4B4 all cells), as
well as for the pooled data set (CA2, Figure 4A5, average;
CA1, Figure 4B5 average). Results shown in Figures 4A5,B5
indicate that although we observed a significant reduction
in the amplitude of EPSCs induced by CCPA in CA2 and
CA1, respectively, we found no significant change in the
variability of EPSCs to suggest whether CCPA is acting pre-
or postsynaptically. Although these data do not rule out the
possibility that the suppression of EPSCs in both CA2 and
CA1 resulted, in part, fromA1R-mediated changes in presynaptic
glutamate release, they do argue against a robust involvement
of several of the known mechanisms, including regulation of
presynaptic calcium, which would have been reflected in the
magnitude of PPF observed.
To exclude the possibility that the synaptic depression
observed in CA2 and CA1 neurons resulted from A1R-
dependent changes in neuronal excitability induced by
CCPA, we tested the effects A1R activation on the intrinsic
membrane properties of CA2 and CA1 neurons. There was
no significant effect of CCPA on the number of action
potentials elicited by suprathreshold current injection or on
the resting membrane potential of pyramidal neurons in
CA2 (spikes, F(9,120) = 0.03, P > 0.99, n = 7, Figures 5A1,2;
RMP, t(6) = 1.89, P = 0.108, n = 7, Figure 5A3) or CA1
(spikes, F(9,100) = 0.36, P = 0.95, n = 6, Figures 5B1,2; RMP,
t(5) = 0.32, P = 0.759, n = 6, Figure 5B3). Interestingly,
although CCPA had no significant effect on the steady-
state input resistance of neurons in both CA2 and CA1
(data not shown), there was a significant reduction in the
amount of inward rectification induced by CCPA in both
CA2 and CA1 pyramidal cells. The rectification ratio decreased
from 1.38 ± 0.07 to 1.27 ± 0.07 in area CA2 (t(6) = 3.70,
P < 0.05, n = 7, Figures 5A4,5) and from 1.31 ± 0.03 to
1.19 ± 0.01 in CA1 (t(5) = 7.82, P < 0.001, n = 6, Figures 5B4,5)
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FIGURE 4 | Changes in presynaptic function induced by CCPA do not differ
between CA2 and CA1. Paired-pulse facilitation (PPF; 50 ms interpulse
interval) did not change significantly following 5-min bath-application of CCPA
in area CA2 (A1,2) or area CA1 (B1,2). The CCPA-mediated depression of
EPSCs (open circles) is shown together with PPF (filled circles) for illustration
purposes in (A1,B1). Inset traces in (A1,B1) are from representative
experiments at the times indicated by the numbers. Note that although CCPA
reduced the amplitude of synaptic responses, PPF was unchanged when the
responses were scaled to the baseline (inset; scaled) in both CA2 and CA1.
(A3–5,B3–5) The coefficient of variation (1/CV2) was computed for 10-min
epochs of stable EPSCs recorded during the baseline period and at the end
of the experiment. Bath-application of CCPA increased response-to-response
variability calculated during the last 10-min of recording as indicated by a
slight reduction in 1/CV2 for CA2 (A3) and CA1 (B3), but the reduction was
not significantly different from the baseline at either recording site. Normalized
1/CV2 for the last 10-min of the experiment is expressed as a ratio of the
baseline and plotted against the normalized amplitude of EPSCs for each
experiment (CA2, all cells, A4; CA1, all cells, B4) and averaged data (CA2,
average, A5; CA1, average, B5). Results are shown in (A5,B5) indicate that
although there is a significant reduction in the amplitude of EPSCs induced by
CCPA in CA2 and CA1, respectively, there is no significant change in the
variability of evoked responses to suggest whether CCPA was acting on A1Rs
located pre- or postsynaptically. ns, not significant.
following bath-application of 100 nM CCPA. Indeed, there
was a marked reduction in the ‘‘sag’’ present in the voltage
FIGURE 5 | CCPA-mediated changes in inward rectification are similar in
both CA2 and CA1. The number of spikes elicited in response to depolarizing
current steps was the same in CA2 and CA1 before and 15 min after a brief
5-min-long application of 100 nM CCPA [A1,B1, representative spikes
triggered by a +40 pA current step; (A2,B2), input-output data for spikes
initiated by suprathreshold injection of multiple current steps up to 100 pA].
There was also no significant change in the resting membrane potential (RMP)
of neurons recorded in CA2 (A3) and CA1 (B3) before and after CCPA.
Inward rectification was quantified by expressing the peak input resistance as
a proportion of the steady-state input resistance (rectification ratio).
Rectification ratios decreased significantly following CCPA treatment in both
CA2 (A4,5) and CA1 (B4,5), an effect attributed largely to a CCPA-mediated
change in peak input resistance (see representative traces for CA2, A4, and
CA1, B4). *p < 0.05, ns, not significant.
responses to −100 pA current steps induced by CCPA in
both CA2 (Figure 5A4) and CA1 (Figure 5B4) neurons.
These data suggest that activation of A1Rs has a minimal
effect on the overall excitability of principal neurons in the
hippocampus and that A1Rs may regulate the activity of
transmembrane currents responsible for inward rectification
at hyperpolarized membrane potentials (perhaps via the
hyperpolarization-activated nonspecific cation current, Ih).
Previously, A1R activation has been shown to activate G-
protein-activated K+ channels (or GIRKS) to inhibit the activity
of CA1 neurons (Trussell and Jackson, 1987; Lüscher et al., 1997;
Wetherington and Lambert, 2002).
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FIGURE 6 | The A1R-mediated depression of EPSCs in CA2 and CA1 does not require activation of NMDARs, p38 MAP Kinase, or protein phosphatase 2A.
Except for a significant enhancement of CCPA-induced depression by 50 µM AP5 in area CA2 (A1), blockade of N-methyl-D-aspartate (NMDA) receptors, p38 MAP
kinase or protein phosphatase 2A with 50 µM AP5, 1 µM SB203580 or 100 nM fostriecin (latency indicated by the black bars), respectively, did not affect the
depression of EPSCs induced by 5-min bath-application of CCPA in CA2 (A1,C1,D1) or CA1 (A2,C2,D2). Also, the constant synaptic drive was not required for the
induction of A1R-mediated synaptic depression in the hippocampus. A temporary pause in the delivery of test stimulation to the Schaffer collaterals for 30 min during
and after application of CCPA (Stim Paused) was similarly without effect in either recording site (CA2, B1; CA1, B2).
Mechanisms Underlying the A1R-Mediated
Synaptic Depression in CA2 and CA1
To determine whether the depression of EPSCs induced by
CCPA was mechanistically similar to other forms of synaptic
depression in the hippocampus, we applied treatments that
have been shown to affect synaptic function in other models
of synaptic plasticity. Because activity-dependent forms of
long-term depression (LTD) can rely on activation of NMDA
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receptors (Dudek and Bear, 1992), we tested whether the NMDA
receptor antagonist, AP5, would block the CCPA-mediated
depression shown in Figures 2–4. Co-application of 50 µM
AP5 with CCPA was not sufficient to block the A1R-mediated
depression of EPSCs in both CA2 and CA1. Indeed, in area
CA1, EPSCs were depressed significantly to 33.53 ± 10.15% of
baseline when assessed during the last 5-min of the experiment
(F(2,14) = 26.78, P < 0.0001, n = 5, Figure 6A2). Although
EPSCs were depressed by the co-application of CCPA and
AP5 relative to untreated controls (Tukey P< 0.0001), responses
did not differ significantly from slices treated with CCPA
alone (Tukey P = 0.206). Interestingly, in area CA2, the
co-application of AP5 significantly enhanced the depression of
synaptic transmission induced by CCPA (see Figure 6A1). EPSCs
were reduced to 34.57 ± 4.32% of baseline in slices treated
with both AP5 and CCPA compared to a reduction of only
61.81± 9.38% for slices treated with CCPA alone (F(2,15) = 22.66,
P < 0.0001, n = 5, Tukey P < 0.05). It is unclear why blockade of
NMDARs facilitates the CCPA-mediated suppression of EPSCs
in area CA2, but activation of NMDARs is not a requirement
for induction of A1R-mediated synaptic depression in either
CA2 or CA1.
We have shown previously that constant synaptic stimulation
of the Schaffer collaterals is not required for the induction
of A1R-mediated synaptic potentiation in area CA2 (Simons
et al., 2012). In the current study, the depression of EPSCs
induced by CCPA was also unaffected by a temporary pause
in the delivery of test stimulation during the experiment.
Responses in CA2 were depressed to 47.11 ± 9.87% of baseline
despite test stimulation being suspended for a 30-min period
during and after bath-application of CCPA (F(2,15) = 11.83,
P < 0.001, n = 5; Figure 6B1). Although the amplitude of
EPSCs was depressed significantly relative to untreated controls
(Tukey P < 0.01), pausing test stimulation did not affect
the magnitude of the CCPA-mediated depression-induced in
CA2 once synaptic stimulation was resumed (Tukey P = 0.427;
compared to CCPA-treated slices receiving test stimulation every
20 s). Similar results were obtained in recordings made from
neurons in area CA1 (EPSCs depressed to 52.21 ± 10.30% of
baseline, F(2,14) = 17.51, P < 0.001, n = 5; control vs. Stim
Paused, Tukey P < 0.001; Stim Paused vs. Stim Continuous,
Tukey P = 0.999; Figure 6B2). These results indicate that
repeated test stimulation of the Schaffer collaterals is not a
prerequisite for inducing A1R-dependent depression of EPSCs
by CCPA.
Previous work has shown that the activity of p38 MAP kinase
contributes to A1R-mediated synaptic depotentiation (Liang
et al., 2008) and depression (Brust et al., 2006) in CA1 neurons.
As such, we tested whether inhibition of p38 MAP kinase would
block the induction of CCPA-mediated synaptic depression in
Schaffer collateral inputs to CA2 and CA1 neurons in juvenile
slices. Inclusion of 1 µM SB203580 in the internal electrode
solution was not sufficient to prevent the induction of A1R-
dependent synaptic depression in the hippocampus. In area CA2,
synaptic responses were significantly depressed to 48.49± 18.6%
of baseline relative to untreated controls (F(2,14) = 7.21, P < 0.01,
Tukey P < 0.05, n = 4, Figure 6C1), and responses did not
differ from those evoked in separate experiments in which CCPA
was applied without the kinase inhibitor (Tukey P = 0.651). In
contrast to previous work, inhibition of p38 MAP kinase also
did not block A1R-mediated synaptic depression in hippocampal
area CA1. EPSCs were depressed to 64.65 ± 12.09% of baseline
by CCPA relative to controls (F(2,12) = 16.78, P < 0.001, Tukey
P< 0.05, n = 3, Figure 6C2), and themagnitude of the depression
was similar to experiments in which CCPA was applied alone
(Tukey P = 0.535). Thus, in slices from juvenile animals, the
activity of p38 MAP kinase does not appear to play a significant
role in A1R-dependent synaptic depression induced by 100 nM
CCPA in either recording site.
There is significant data to support a key role for
protein phosphatases in activity-dependent forms of LTD in
the hippocampus (Mauna et al., 2011), including protein
phosphatase 2A (Stockwell et al., 2015). Here, we investigated
whether the inhibiting activity of protein phosphatase 2A with
fostriecin would block the A1R-mediated synaptic depression
induced by CCPA. Similar to the negative results described
above for various other inhibitors, co-application of 100 nM
fostriecin with CCPA did not block the A1R-mediated synaptic
depression in either CA2 or CA1. The amplitude of EPSCs
was reduced significantly to 63.19 ± 14.43% of baseline and
to 58.63 ± 7.30% of baseline in CA2 and CA1, respectively,
relative to untreated controls (CA2, F(2,16) = 5.03, P < 0.05,
n = 6, Tukey P < 0.05, Figure 6D1; CA1, F(2,15) = 19.57,
P < 0.0001, n = 6, Tukey P < 0.001, Figure 6D2). Further, the
depression of synaptic responses in CA2 and CA1 induced by
CCPA in the presence of fostriecin did not differ significantly
from the depression induced by CCPA alone (CA2, Tukey
P = 0.995; CA2, Tukey P = 0.789). Although we do not provide
positive evidence that fostriecin was effective, we note that we
used 5 times the concentration found effective for glutamate
receptor internalization (Stockwell et al., 2015). Nevertheless,
these data suggest that the activity of protein phosphatase 2A
is not required for A1R-mediated synaptic depression in the
hippocampus and that other A1R-mediated intracellular signals
are likely involved.
Divergence in A1R-Mediated Intracellular
Signaling in CA2 and CA1 Neurons
Adenosine A1Rs couple to Gi/o ( Munshi et al., 1991; Dunwiddie
and Masino, 2001), and as such, activation of A1Rs by selective
agonists should reduce the activity of adenylyl cyclase and
constrain the production of cAMP. If the CCPA-mediated
synaptic depression in CA2 and CA1 is linked to an A1R-
dependent decrease in postsynaptic levels of cAMP then the
depression of EPSCs would not necessarily be expected to
occur as rapidly as we observe here, even though A1R agonists
are known to stimulate internalization of glutamate receptors
over long periods (Stockwell et al., 2015). For cAMP levels
to drop so precipitously, enzymatic degradation of cAMP
would presumably be required. For this reason, we tested
whether differences in A1R-mediated synaptic plasticity between
areas CA2 and CA1 might reflect regional variations in
phosphodiesterase activity in the hippocampus. Indeed, the
expression of several isoforms of phosphodiesterase differs across
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hippocampal subfields in mice. Specifically, expression of Pde8b,
Pde10a, and Pde11a is highest in area CA1, whereas Pde4d
is expressed exclusively in area CA2 (see Figure 7A; Lein
et al., 2006). Incidentally, both Pde8b and Pde11a increase
significantly during aging (Kelly et al., 2014). To determine
whether inhibition of phosphodiesterase activity mimics effects
observed using various A1R antagonists on synaptic transmission
in the hippocampus (i.e., induces synaptic potentiation), we
bath-applied the phosphodiesterase inhibitor, rolipram, and
assessed its effects on evoked synaptic responses in CA2 and
CA1. Continuous application of 10 µM rolipram for 50-min
induced a slight facilitation of EPSCs in CA2–132.70 ± 13.59%
of baseline, but this increase did not differ significantly from
control responses (t11 = 2.08, P = 0.061, n = 7, Figure 7B1).
In CA1, however, EPSCs were facilitated to 154.10 ± 14.99%
of baseline by rolipram, and this potentiation was significant
relative to responses evoked in control experiments (t12 = 3.44,
P< 0.01, n = 7, Figure 7B2). Despite this increase, the magnitude
of synaptic potentiation induced by rolipram did not differ
significantly between CA2 and CA1 (t(12) = 1.06, P = 0.3104,
Figure 7B3).
Interestingly, rolipram’s ability to induce a significant
potentiation of EPSCs in area CA1 was coincident with its
ability to block the synaptic depression induced by CCPA. For
these experiments, slices were first pre-incubated in oxygenated
rolipram (10 µM rolipram in normal ASCF) for at least
40 min before being transferred to the recording chamber. This
pre-incubation period was then followed by the continuous
perfusion of 10 µM rolipram for the entire duration of
the experiment. Under these conditions, the A1R-mediated
depression of synaptic responses typically induced by 5-min
application of CCPA was blocked in Schaffer collateral inputs to
CA1 (Figure 7C2), but not to CA2 (Figure 7C1). In area CA1 of
rolipram-treated slices, EPSCs remained stable at 91.80 ± 5.77%
of baseline when assessed during the last 5-min of recording,
and responses did not differ significantly from untreated controls
(F(2,15) = 19.55, P < 0.0001, n = 6, Tukey P = 0.432). However, in
CA2, rolipram treatment had no effect on the depression induced
by CCPA (EPSCs depressed to 60.28 ± 11.79% of baseline,
F(2,16) = 6.78, P < 0.01, n = 6, Rolipram + CCPA vs. control,
Tukey P < 0.05). In line with this, the depression of EPSCs was
significantly greater in CA2 than in CA1 (t(10) = 2.40, P < 0.05,
FIGURE 7 | The A1R-mediated depression of synaptic responses in CA1 relies on phosphodiesterase activity. (A) The expression of several phosphodiesterases
(PDEs) differs in mouse CA1 and CA2 with Pde4d showing the highest expression in CA2 (arrow), but with Pde8b, Pde10a, and Pde11a showing the lowest levels in
CA2 compared to area CA1 (arrows; Lein et al., 2006). (B1–3) The PDE inhibitor rolipram (10 µM) induced a slow-onset potentiation of EPSCs that did not differ
between CA1 and CA2. However, pre-treating slices with rolipram for 40 min followed by its continuous perfusion throughout the experiment blocked the
CCPA-mediated depression of EPSCs in CA1, but not in CA2 (C1–3). *p < 0.05, ns, not significant.
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FIGURE 8 | Inhibition of protein kinase A (PKA) with KT5720 induces a slow-onset depression of synaptic transmission in area CA2, but not in area CA1. (A1–3)
Including the PKA inhibitor, KT5720 (2 µM, indicated by the black bar), in the intracellular recording solution caused a significant decrease in the amplitude of EPSC
in CA2, but not in CA1. (B1–3) Interestingly, the internal application of the more selective inhibitor of PKA, PKI (30 µM; black bar), was without effect on EPSCs
recorded in CA2 or CA1. PKI was obtained from Santa Cruz Biotechnology. *p < 0.05, ns, not significant.
Figure 7C3). This suggests that a mechanism other than robust
phosphodiesterase activity may be at work in CA2 neurons to
cause synaptic depression in response to A1R agonists.
Although some phosphatases, such as protein phosphatase
2A and protein phosphatase 4, are not required for the decline
in synaptic strength induced by CCPA (see Figures 6D1,2), it is
possible that blocking the activity of key protein kinases directly
may be sufficient to induce a lasting depression of synaptic
transmission in the hippocampus that resembles the depression
mediated by activation of A1Rs. This depends critically, though,
on whether the depression of EPSCs involves the downregulation
of cAMP-dependent protein kinase activity as opposed to
regulation of other cAMP-dependent proteins, such as the
exchange protein activated by cAMP, or EPAC (Sugawara et al.,
2016). Given that PKA is the principal kinase stimulated by
the activity of cAMP, we tested two different PKA inhibitors
for their efficacy in mimicking the CCPA-mediated depression
of EPSCs in CA2 and CA1. Interestingly, 2 µM KT5720, but
not 30 µM PKI, in the internal electrode solution, caused a
slow-onset depression of synaptic responses in CA2. Indeed,
synaptic responses were reduced significantly to 58.01 ± 2.77%
of baseline by KT5720 in CA2 relative to untreated controls when
assessed during the last 5-min of the experiment (t(9) = 13.18,
P < 0.0001, n = 5, Figure 8A1). Interestingly, KT5720 had no
effect on the amplitude of EPSCs in CA1 (responses remained
stable at 108.90 ± 17.06% of baseline, t(8) = 0.651, P = 0.533,
n = 3, Figure 8A2; CA2 vs. CA1, t(6) = 3.92, P < 0.01,
Figure 8A3), and inclusion of PKI in the internal electrode
solution had no effect on responses irrespective of recording
site (CA2, EPSCs stable at 100.50 ± 4.12%, t(8) = 0.289,
P = 0.780, n = 4, Figures 8B1,3; CA1, EPSCs stable at
117.60 ± 8.24%, t(9) = 2.21, P = 0.054, Figures 8B2,3; CA2 vs.
CA1, t(6) = 1.86, P = 0.113, Figure 8B3) or concentration (10µM,
data not shown).
Finally, because at least three isoforms of adenylyl cyclase
are highly expressed in area CA2 in the mouse (Visel et al.,
2006), including Adcy1, Adcy5, and Adcy6 (see Figure 9A)—an
effect observed even in animals as young as P7 (for Adcy1,
Lein et al., 2006)—we tested whether direct stimulation of
adenylyl cyclases could mimic the effects of A1R antagonists
and induce synaptic potentiation in area CA2 in slices from
juvenile animals. Indeed, bath application of 10 µM forskolin
caused a rapid potentiation of EPSCs in CA2 neurons that
persisted for the entire duration of the experiment. EPSCs were
potentiated to 170.20 ± 10.16% of baseline (Figure 9B1, n = 6),
and this facilitation was significant relative to responses in
age-matched and untreated controls (t(10) = 6.62, P < 0.0001,
Figure 9B2). As predicted based on our work previously (Simons
et al., 2012), there was no effect of forskolin on responses in
CA1 neurons (responses remained stable at 118.60 ± 17.89%
of baseline, t(11) = 0.866, P = 0.405, n = 7, Figures 9C1,2).
Not surprisingly, the magnitude of the synaptic potentiation
induced by forskolin was significantly greater in CA2 than
in CA1 (t(11) = 2.39, P < 0.05, Figures 9D1,2). Taken
together, these data suggest that although A1R expression
does not differ substantially across the hippocampus at
early postnatal ages, the activity of critical A1R-dependent
intracellular signals—including adenylyl cyclase, protein kinase,
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FIGURE 9 | Activation of adenylyl cyclases enhances EPSCs in CA2 in
juvenile brain slices. (A) Expression of several adenylyl cyclases is greater in
CA2, including Adcy1, Adcy5 (shown; arrows), and Adcy6 (Lein et al., 2006).
(B1,2) Bath-application of the adenylyl cyclase activator, forskolin (10 µM), for
10 min induced a lasting potentiation of EPSCs in area CA2 that was
significantly greater than responses in age-matched and untreated control
experiments. However, forskolin had no lasting effect on transmission in area
CA1 (C1,2). (D1,2) The response to forskolin was significantly greater in
CA2 than in CA1 (data re-plotted from (B1,C1). *p < 0.05, ns, not significant.
and phosphodiesterase activity—differ considerably between
CA1 and CA2, thus resulting in an overall effect that essentially
mimics the adult state.
DISCUSSION
In this study, we pursued two lines of inquiry related to adenosine
receptor expression in the hippocampus. First, we tested whether
the use of a selective A1R agonist to induce synaptic depression
in CA2 and CA1 would better reflect changes in the staining
pattern of A1Rs in the hippocampus than the application of
A1R antagonists, such as caffeine or DPCPX. Second, we tested
several of the known intracellular signals linked to activation
of A1Rs and whether they might account for the dramatic
effects of A1R antagonists observed in CA2 neurons in slices
prepared from young animals (Simons et al., 2012). Indeed,
both lines of inquiry produced data to support the findings
of Ochiishi et al. (1999) in that—at least in Sprague–Dawley
rats—A1Rs in the hippocampus are distributed evenly across
areas CA2 and CA1 in juvenile animals, and that A1R expression
in CA2 neurons increases markedly during typical adolescent
development (see Figure 3). Our study also highlights critical
intracellular signals downstream to activation of A1Rs that
contribute to the robust effects of adenosine receptor antagonists
observed in area CA2 during early postnatal development,
which occur before any enrichment of A1Rs in CA2
pyramidal neurons.
Adenosine receptors localized in presynaptic boutons are
known to regulate neurotransmitter release (Prince and Stevens,
1992; Wetherington and Lambert, 2002; Scammell et al., 2003),
but they also play critical roles in mediating the activity of key
postsynaptic signaling cascades and in controlling intrinsic
membrane conductances that affect neuronal excitability
(Greene and Haas, 1985; Gerber et al., 1989). Here, we
observed several such effects following bath application of
the selective A1R agonist CCPA that do not differ between
areas CA2 and CA1, including changes in rectification ratios
and synaptic function (see Figures 2, 5, respectively) that are
similar to those reported previously (Greene and Haas, 1991;
Dunwiddie and Masino, 2001). It is unclear, however, whether
the lasting effects of CCAP on synaptic and intrinsic excitability
shown in the current study are due to A1Rs located pre- or
postsynaptically in CA2 and CA1 (but see Figure 4). Notably,
though, adenosine receptors have been shown to interfere
with postsynaptic mechanisms required for the maintenance
of activity-dependent forms of LTP in area CA1 (Arai et al.,
1990; Rex et al., 2005). The possibility of reversing LTP in
CA2 neurons by subsequent activation of A1Rs, however,
was not tested in the current study because LTP of synaptic
responses rarely occurs in Schaffer collateral inputs to CA2 when
performing typical whole-cell slice experiments in vitro with
2 mM extracellular calcium in the bathing medium (Zhao
et al., 2007; Simons et al., 2009; Chevaleyre and Siegelbaum,
2010). Our data presented here do not rule out a role for A1Rs
regulating GABAergic transmission, such as has been described
previously (Jeong et al., 2003; Rombo et al., 2014), but we note
that Muñoz and Solís (2019) found no effect of picrotoxin on
CA1/CA2 differences in caffeine-induced potentiation. This is
particularly relevant in light of the findings that CA2 of rats
and mice has a higher density of some types of GABAergic
interneurons than CA1 (Piskorowski and Chevaleyre, 2013;
Botcher et al., 2014).
Regarding the effects of A1R activation on presynaptic
terminals, our primary evidence against the idea of a
CA1/CA2 difference in presynaptic neurotransmitter release
is based on our analysis of PPF. This technique presumes that
the identical terminals activated by the first pulse are also
activated by the second, and so neurotransmitter release may
be underestimated in our experiments to a large degree. We
note that although we did not see significant effects of CCPA
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(A1R agonist) on PPF or differences between CA1 and CA2 in
slices from juvenile animals, Muñoz and Solís (2019) recently
reported that the magnitude of PPF differed between CA1 and
CA2 after caffeine (A1R antagonist) treatment in slices from
older animals. The high variance in synaptic responses seen
with whole-cell recordings compared with the low variance
in responses recorded in field potentials (Muñoz and Solís,
2019) may have also contributed to the differences in findings
in the two studies. Additional experiments with more cells
may reveal significant findings, but the lack of differences
between CA1 and CA2 in: (a) A1R staining at P14 (Ochiishi
et al., 1999), and (b) CCPA-induced depression (Figure 3)
at P14 is consistent with our findings of modest/variable
changes in PPF. Selective disruption of Gi/o coupling in
the recorded neuron or localized knockout of Adora1 may
eventually resolve the question of the presynaptic effects
of adenosine.
Although the developmentally-regulated pattern of
immunolabeling for the A1R in area CA2 first shown by
Ochiishi et al. (1999) has not been replicated successfully
by us or by others using commercially-available antibodies
(Rex et al., 2005), our finding that an A1R agonist was
sufficient to cause an age-dependent change in synaptic
function in both CA2 and CA1 directly supports the idea
of a developmental shift in the distribution of A1Rs across
the hippocampus (see Figure 3). Interestingly, previous
immunolabeling work has shown that 5’-nucleotidase—an
enzyme required to generate adenosine from ATP—is highly
enriched in area CA2 in both the mouse and the gerbil (Lee
et al., 1986). Nevertheless, it had yet to be reconciled how
a blockade of A1Rs by caffeine or another A1R antagonist
could induce a robust potentiation of synaptic responses in
area CA2 at concentrations that do little in CA1 and CA3
(Simons et al., 2012). Here, we provide evidence showing
how several A1R-mediated intracellular signals differ between
areas CA2 and CA1, and this suggests that differences in
A1R-mediated synaptic plasticity observed in slices prepared
from juvenile animals may be due to mechanisms other than
those linked directly to the expression pattern of A1Rs in the
hippocampus. Specifically, both kinase activity, required for
maintaining synaptic responses (see Figure 8), and robust
response to forskolin in CA2 neurons (see Figure 9) indicate
that postsynaptic currents in CA2 pyramidal cells are especially
sensitive to manipulations of cAMP and changes in substrate
phosphorylation, even in tissue obtained from young animals.
Alternatively, rolipram-sensitive phosphodiesterase activity,
which is required for A1R-mediated synaptic depression in
CA1 but not in CA2 (see Figure 7), may be responsible for
the blunted potentiating effects of forskolin and various A1R
antagonists in area CA1. Importantly, though, the two are not
likely to be mutually exclusive and both may contribute to the
relative effectiveness of A1R antagonists to potentiate EPSCs in
slices from young rats. Regional differences in the expression
of A1Rs may be sufficient to explain the differential effects of
CCPA on synaptic responses in adult tissue, but they would
likely be in addition to any regional differences in intracellular
signaling molecules described above. For example, both of the
calcium-activated adenylyl cyclases, AC1 and AC8, increase
with age in mouse hippocampus (Nicol et al., 2005; Conti et al.,
2007). In addition, the antagonist and agonist responses may be
controlled by adenosine re-uptake and metabolism pathways,
any of which may also be developmentally controlled. Thus the
CPPA response, presuming it is neither taken up or metabolized,
may reflect partial occlusion by these other factors regulating
adenosine tone; caution must be taken when interpreting
these data.
The precise mechanism underlying the induction of
CCPA-mediated synaptic depression in Schaffer collateral inputs
to CA2 and CA1 remains unknown, but it is clear that NMDA
receptors or constant synaptic stimulation are not required (see
Figures 6A1,2,B1,2). These findings indicate that mechanisms
typically involved in the induction of activity-dependent forms
of synaptic depression in the hippocampus are not required here
[but see Pagani et al. (2014) for mechanisms of Avpr1b-mediated
synaptic potentiation in CA2], and this is consistent with the
findings of Simons et al. (2012) who demonstrated a role for
enhanced activity of PKA in the expression of A1R-mediated
synaptic potentiation in area CA2 induced by caffeine or DPCPX
(Simons et al., 2012). Also, previous work examining the effects
of the A1R agonist CPA on glutamate receptor phosphorylation
and internalization indicates a key role for protein phosphatase
2A (Stockwell et al., 2015), which has also been implicated
in activity-dependent forms of LTD (Mauna et al., 2011).
Although we used a different A1R agonist for a much shorter
incubation period than in the previous report, we found no
effect of the protein phosphatase 2A inhibitor, fostriecin, on
the CCPA-mediated depression of EPSCs in either CA2 or CA1
(see Figures 6D1,2). We also found that inhibition of p38 MAP
kinase, which has been implicated in both adenosine-mediated
signaling and NMDA receptor-dependent LTD (Bolshakov et al.,
2000; Brust et al., 2006; Liang et al., 2008), was similarly without
effect (see Figures 6C1,2). Thus, although there are several forms
of LTD (Sanderson et al., 2016; Pinar et al., 2017), many of which
have underlying mechanisms shared with adenosine receptor-
mediated reductions in synaptic currents, our data suggest that
NMDARs, phosphatase 2A, or p38 MAP kinase are unlikely to
be critical for the type CCPA-induced depression reported here.
Further studies would be required to determine whether other
mechanisms associated with pre- and/or post-synaptic forms
of LTD, such as those requiring endocannabinoids or mGluRs,
interact with A1R-mediated depression (Atwood et al., 2014;
Kano, 2014; Olmo et al., 2016).
A difficult result to interpret is the observation that internal
application of the different protein kinase A inhibitors elicited
different effects across the various hippocampal subfields
(KT5720 and PKI; see Figures 8A,B, respectively). Specifically,
KT5720 caused a slow-onset decay in the amplitude of EPSCs
recorded in CA2 neurons, yet it had no effect on transmission
in CA1 (see Figures 8A1–3). Interestingly, PKI in the internal
electrode solution did not affect synaptic responses evoked in
either recording site (see Figures 8B1–3). Based on the findings
of Kameyama et al. (1998) who observed a rundown of responses
in CA1 with 10 µM PKI, we had expected a similar result
here. However, our initial attempts with 10 µM were without
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effect (data not shown), and even a 30 µM concentration of
PKI failed to induce changes in synaptic transmission after
1 h of recording (see Figures 8B1,2). Although possibly the
rundown observed with PKI in the previous study was due
to the intracellular recording technique (i.e., sharp intracellular
recordings using an internal solution containing only salts), we
did obtain the expected result with a different PKA inhibitor
using a different slice recording protocol (KT5720; whole-cell
patch-clamp recordings with ATP and GTP in the internal
solution, see Figure 8A1). Indeed, the two inhibitors are known
to act in slightly different ways to inhibit the activity of PKA,
with PKI binding the catalytic subunits of the kinase and
KT5720 acting as a competitive antagonist at the ATP binding
sites on the catalytic domains (Murray, 2008). KT5720 is thought
to be the less selective inhibitor out of the two, raising the
possibility that its effects on synaptic responses in CA2 neurons
may be due actions on other intracellular kinases, such as
MEK or MAPK (Murray, 2008). Alternatively, if the PKA is
bound together in complexes, such as AKAPs (Nygren and
Scott, 2015), then the PKI binding site may not be accessible
to exogenously applied compounds. Nevertheless, we believe
that the results here indicate that various targets of PKA,
including glutamate receptors, may be differentially regulated
in both CA2 and CA1, and this may partly explain the robust
potentiating effects of A1R antagonists in area CA2 in slices
obtained from young animals despite the lack of any obvious
enrichment of A1Rs.
Hippocampal area CA2 has only recently been appreciated
for its role in various forms of cognition. Indeed, evidence has
been amassed linking CA2 to a wide array of social behaviors.
Specifically, lesioning area CA2 or silencing CA2 neurons via
genetic manipulations to prevent glutamate release results in
deficits in social recognition memory (Hitti and Siegelbaum,
2014; Stevenson and Caldwell, 2014), deletion of a CA2-enriched
gene, Avpr1b, reduces aggressive behavior in mice (Wersinger
et al., 2002; Pagani et al., 2014) and optogenetic stimulation
of vasopressinergic axons in CA2 enhances social recognition
memory (Smith et al., 2016). Although A1Rs are expressed in
neurons throughout the brain, if their function is greatest in
area CA2 where the receptor is highly concentrated then it is
not surprising that an A1R agonist impairs social recognition
memory and that caffeine enhances it (Prediger and Takahashi,
2005). Moreover, A1R knockout mice display no deficits in
spatial learning, but they do exhibit pronounced anxiety-like
behaviors and aggression (Giménez-Llort et al., 2002, 2005).
Finally, chronic administration of caffeine increases aggressive
behavior in rats (Fredholm et al., 1999) and enhances both
the length and branching pattern of basal dendrites in CA1,
including the density of spines on these dendrites (Vila-Luna
et al., 2011) which are the main targets of CA2 neurons (Kohara
et al., 2013). Thus, links between adenosine receptor function,
various social behaviors, and area CA2 may be worthy of further
consideration. Our findings indicate that downstream signaling
of A1Rs is what distinguishes CA2 from CA2 early in postnatal
development. Further, they suggest that the modulation of key
neurotransmitter systems in the hippocampus, like adenosine,
may differ depending on the stage of development.
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